• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖分子及纳米颗粒的摄取与细胞毒性:分子量和脱乙酰度的影响

Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation.

作者信息

Huang Min, Khor Eugene, Lim Lee-Yong

机构信息

Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore 117543.

出版信息

Pharm Res. 2004 Feb;21(2):344-53. doi: 10.1023/b:pham.0000016249.52831.a5.

DOI:10.1023/b:pham.0000016249.52831.a5
PMID:15032318
Abstract

PURPOSE

To evaluate the effects of molecular weight (Mw) and degree of deacetylation (DD) on the cellular uptake and in vitro cytotoxicity of chitosan molecules and nanoparticles.

METHODS

Chemical depolymerization and reacetylation produced chitosans of Mw 213,000 to 10,000 and DD 88-46%, respectively. Chitosan was labeled with FITC and transformed into nanoparticles by ionotropic gelation. Uptake of chitosan by confluent A549 cells was quantified by fluorometry, and in vitro cytotoxicity was evaluated by the MTT and neutral red uptakeassays.

RESULTS

Nanoparticle uptake was a saturable event for all chitosan samples, with the binding affinity and uptake capacity decreasing with decreasing polymer Mw and DD. Uptake fell by 26% when Mw was decreased from 213,000 to 10,000, and by 41% when DD was lowered from 88% to 46%; the uptake data correlated with the zeta potential of the nanoparticles. Uptake of chitosan molecules did not exhibit saturation kinetics and was less dependent on Mw and DD. Postuptake quenching with trypan blue indicated that the cell-associated chitosan nanoparticles were internalized, but not the cell-associated chitosan molecules. Chitosan molecules and nanoparticles exhibited comparable cytotoxicity, yielding similar IC50 and IC20 values when evaluated against the A549 cells. Cytotoxicity of both chitosan entities was attenuated by decreasing polymer DD but was less affected by a lowering in Mw.

CONCLUSIONS

Transforming chitosan into nanoparticles modified the mechanism of cellular uptake but did not change the cytotoxicity of the polymer toward A549 cells. Chitosan DD had a greater influence than Mw on the uptake and cytotoxicity of chitosan nanoparticles because of its effect on the zeta potential of the nanoparticles.

摘要

目的

评估分子量(Mw)和脱乙酰度(DD)对壳聚糖分子及纳米粒细胞摄取和体外细胞毒性的影响。

方法

通过化学解聚和再乙酰化分别制备了Mw为213,000至10,000且DD为88% - 46%的壳聚糖。壳聚糖用异硫氰酸荧光素(FITC)标记,并通过离子凝胶法转化为纳米粒。采用荧光法对汇合的A549细胞摄取壳聚糖的情况进行定量,通过MTT法和中性红摄取试验评估体外细胞毒性。

结果

对于所有壳聚糖样品,纳米粒摄取是一个可饱和过程,其结合亲和力和摄取能力随聚合物Mw和DD的降低而下降。当Mw从213,000降至10,000时,摄取量下降26%;当DD从88%降至46%时,摄取量下降41%;摄取数据与纳米粒的ζ电位相关。壳聚糖分子的摄取未表现出饱和动力学,且对Mw和DD的依赖性较小。用台盼蓝进行摄取后淬灭表明,与细胞相关的壳聚糖纳米粒被内化,但与细胞相关的壳聚糖分子未被内化。壳聚糖分子和纳米粒表现出相当的细胞毒性,在针对A549细胞进行评估时产生相似的半数抑制浓度(IC50)和20%抑制浓度(IC20)值。两种壳聚糖实体的细胞毒性均通过降低聚合物DD而减弱,但受Mw降低的影响较小。

结论

将壳聚糖转化为纳米粒改变了细胞摄取机制,但未改变聚合物对A549细胞的细胞毒性。壳聚糖DD对壳聚糖纳米粒的摄取和细胞毒性的影响大于Mw,因为其对纳米粒的ζ电位有影响。

相似文献

1
Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation.壳聚糖分子及纳米颗粒的摄取与细胞毒性:分子量和脱乙酰度的影响
Pharm Res. 2004 Feb;21(2):344-53. doi: 10.1023/b:pham.0000016249.52831.a5.
2
Uptake of FITC-chitosan nanoparticles by A549 cells.A549细胞对异硫氰酸荧光素标记的壳聚糖纳米粒的摄取。
Pharm Res. 2002 Oct;19(10):1488-94. doi: 10.1023/a:1020404615898.
3
Ultrasonication of chitosan and chitosan nanoparticles.壳聚糖及壳聚糖纳米颗粒的超声处理
Int J Pharm. 2003 Oct 20;265(1-2):103-14. doi: 10.1016/s0378-5173(03)00408-3.
4
[Study of the uptake of chitosan oligosaccharide nanoparticles by A549 cells].[A549细胞对壳寡糖纳米颗粒摄取的研究]
Yao Xue Xue Bao. 2004 Mar;39(3):227-31.
5
Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation.壳聚糖载体的转染效率:聚合物分子量和脱乙酰度的影响。
J Control Release. 2005 Sep 2;106(3):391-406. doi: 10.1016/j.jconrel.2005.05.004.
6
Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles.壳聚糖及相关胰岛素在Caco-2细胞单层中的摄取:壳聚糖分子与壳聚糖纳米颗粒的比较
Pharm Res. 2003 Nov;20(11):1812-9. doi: 10.1023/b:pham.0000003379.76417.3e.
7
Uptake of oleoyl-chitosan nanoparticles by A549 cells.A549细胞对油酰壳聚糖纳米颗粒的摄取。
Nanomedicine. 2008 Sep;4(3):208-14. doi: 10.1016/j.nano.2008.03.006. Epub 2008 May 27.
8
Fluorescent chitosan functionalized magnetic polymeric nanoparticles: Cytotoxicity and in vitro evaluation of cellular uptake.荧光壳聚糖功能化磁性聚合物纳米颗粒:细胞毒性及细胞摄取的体外评估
J Biomater Appl. 2014 Nov;29(5):761-8. doi: 10.1177/0885328214540349. Epub 2014 Jun 20.
9
The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.聚合物性质对壳聚糖/小干扰RNA纳米颗粒制剂及基因沉默的影响。
Biomaterials. 2007 Feb;28(6):1280-8. doi: 10.1016/j.biomaterials.2006.11.004.
10
Antitumor activity of chitosan from mayfly with comparison to commercially available low, medium and high molecular weight chitosans.蜉蝣壳聚糖的抗肿瘤活性及其与市售低、中、高分子量壳聚糖的比较
In Vitro Cell Dev Biol Anim. 2018 May;54(5):366-374. doi: 10.1007/s11626-018-0244-8. Epub 2018 Apr 13.

引用本文的文献

1
Efficient Delivery of SARS-CoV-2 Plasmid DNA in HEK-293T Cells Using Chitosan Nanoparticles.使用壳聚糖纳米颗粒在人胚肾293T细胞中高效递送严重急性呼吸综合征冠状病毒2(SARS-CoV-2)质粒DNA。
Pharmaceuticals (Basel). 2025 May 5;18(5):683. doi: 10.3390/ph18050683.
2
Statement concerning the review of the approval of the basic substances chitosan and chitosan hydrochloride when used in plant protection.关于审查壳聚糖和盐酸壳聚糖作为植物保护用基本物质的批准情况的声明。
EFSA J. 2025 Apr 3;23(4):e9318. doi: 10.2903/j.efsa.2025.9318. eCollection 2025 Apr.
3
Comparative assessment of macrophage responses and antileishmanial efficacy in dynamic vs. Static culture systems utilizing chitosan-based formulations.

本文引用的文献

1
The degree of deacetylation of chitosan: advocating the first derivative UV-spectrophotometry method of determination.壳聚糖的脱乙酰度:提倡采用一阶导数紫外分光光度法测定。
Talanta. 1998 Feb;45(4):713-9. doi: 10.1016/s0039-9140(97)00288-9.
2
Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles.壳聚糖及相关胰岛素在Caco-2细胞单层中的摄取:壳聚糖分子与壳聚糖纳米颗粒的比较
Pharm Res. 2003 Nov;20(11):1812-9. doi: 10.1023/b:pham.0000003379.76417.3e.
3
Uptake of FITC-chitosan nanoparticles by A549 cells.
利用基于壳聚糖的制剂在动态与静态培养系统中对巨噬细胞反应和抗利什曼原虫功效的比较评估。
PLoS One. 2025 Mar 11;20(3):e0319610. doi: 10.1371/journal.pone.0319610. eCollection 2025.
4
Progress in the Application of Novel Nanomaterials in Targeted Therapy for Liver Cancer.新型纳米材料在肝癌靶向治疗中的应用进展
Int J Nanomedicine. 2025 Mar 3;20:2623-2643. doi: 10.2147/IJN.S509409. eCollection 2025.
5
Chondroitin Sulphate-Chitosan Based Nanogels Loaded with Naringenin-β-Cyclodextrin Complex as Potential Tool for the Treatment of Diabetic Retinopathy: A Formulation Study.负载柚皮苷-β-环糊精复合物的硫酸软骨素-壳聚糖基纳米凝胶作为治疗糖尿病视网膜病变的潜在工具:一项制剂研究。
Int J Nanomedicine. 2025 Jan 22;20:907-932. doi: 10.2147/IJN.S488507. eCollection 2025.
6
Chitosan Micro/Nanocapsules in Action: Linking Design, Production, and Therapeutic Application.壳聚糖微/纳米胶囊的作用:连接设计、生产与治疗应用
Molecules. 2025 Jan 10;30(2):252. doi: 10.3390/molecules30020252.
7
Chitosan immunomodulation: insights into mechanisms of action on immune cells and signaling pathways.壳聚糖的免疫调节作用:对免疫细胞及信号通路作用机制的见解
RSC Adv. 2025 Jan 10;15(2):896-909. doi: 10.1039/d4ra08406c. eCollection 2025 Jan 9.
8
Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.叶酸修饰壳聚糖纳米粒:新一代抗癌纳米载体。
Mol Cancer. 2024 Oct 31;23(1):244. doi: 10.1186/s12943-024-02163-z.
9
The Role of Inhaled Chitosan-Based Nanoparticles in Lung Cancer Therapy.吸入性壳聚糖基纳米颗粒在肺癌治疗中的作用
Pharmaceutics. 2024 Jul 23;16(8):969. doi: 10.3390/pharmaceutics16080969.
10
Lysosomal Activation Mediated by Endocytosis in J774 Cell Culture Treated with N-Trimethyl Chitosan Nanoparticles.内吞作用介导的溶酶体激活在 N-三甲基壳聚糖纳米颗粒处理的 J774 细胞培养中的作用。
Molecules. 2024 Jul 31;29(15):3621. doi: 10.3390/molecules29153621.
A549细胞对异硫氰酸荧光素标记的壳聚糖纳米粒的摄取。
Pharm Res. 2002 Oct;19(10):1488-94. doi: 10.1023/a:1020404615898.
4
Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors.通过清道夫受体靶向肝脏非实质细胞的琥珀酰化蛋白质体内处置的药代动力学分析:分子大小和负电荷密度对受体体内识别的重要性。
J Pharmacol Exp Ther. 2002 May;301(2):467-77. doi: 10.1124/jpet.301.2.467.
5
Chitosan as a novel nasal delivery system for vaccines.壳聚糖作为一种新型的疫苗鼻腔给药系统。
Adv Drug Deliv Rev. 2001 Sep 23;51(1-3):81-96. doi: 10.1016/s0169-409x(01)00171-5.
6
Chitosan nanoparticles as delivery systems for doxorubicin.壳聚糖纳米颗粒作为阿霉素的递送系统。
J Control Release. 2001 Jun 15;73(2-3):255-67. doi: 10.1016/s0168-3659(01)00294-2.
7
In vitro degradation of chitosan by a commercial enzyme preparation: effect of molecular weight and degree of deacetylation.壳聚糖在一种商业酶制剂作用下的体外降解:分子量和脱乙酰度的影响
Biomaterials. 2001 Jun;22(12):1653-8. doi: 10.1016/s0142-9612(00)00326-4.
8
The cellular delivery of antisense oligonucleotides and ribozymes.反义寡核苷酸和核酶的细胞递送
Drug Discov Today. 2001 Mar 1;6(6):303-315. doi: 10.1016/s1359-6446(00)00326-3.
9
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.壳聚糖-脱氧核糖核酸纳米颗粒作为基因载体:合成、表征及转染效率
J Control Release. 2001 Feb 23;70(3):399-421. doi: 10.1016/s0168-3659(00)00361-8.
10
Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?用于肽口服递送的可生物降解纳米颗粒:聚合物对黏膜摄取有影响作用吗?
Eur J Pharm Biopharm. 2000 Jul;50(1):147-60. doi: 10.1016/s0939-6411(00)00084-9.